Mediators of Inflammation

Mediators of Inflammation / 2014 / Article

Research Article | Open Access

Volume 2014 |Article ID 819731 | 8 pages | https://doi.org/10.1155/2014/819731

Peptidases from Latex of Carica candamarcensis Upregulate COX-2 and IL-1 mRNA Transcripts against Salmonella enterica ser. Typhimurium-Mediated Inflammation

Academic Editor: Sandra Helena Penha Oliveira
Received17 Nov 2013
Revised09 Jan 2014
Accepted24 Jan 2014
Published13 Mar 2014

Abstract

The immunomodulatory properties of a mixture of cysteine peptidases (P1G10) obtained from the fruit lattice of Carica candamarcensis were investigated. P1G10 was obtained from fresh latex samples by chromatography in a Sephadex column and initially administered to Swiss mice (; 1 or 10 mg/kg) via i.p. After 30 min, the mice were injected with carrageenan (0.5 mg/mouse) or heat-killed S. Typhimurium (107 CFU/mL; 100°C/30 min) into the peritoneal cavity. Afterwards, two animal groups were i.p. administered with P1G10 (; 1, 5, or 10 mg/Kg) or PBS 24 hours prior to challenge with live S. Typhimurium (107 CFU/mL). P1G10 stimulated the proliferation of circulating neutrophils and lymphocytes, 6 h after injection of carrageenan or heat-killed bacteria, respectively. Furthermore, survival after infection was dose-dependent and reached 60% of the animal group. On the other hand, control mice died 1–3 days after infection. The examination of mRNA transcripts in liver cells 24 h after infection confirmed fold variation increases of 5.8 and 4.8 times on average for IL-1 and COX-2, respectively, in P1G10 pretreated mice but not for TNF-α, IL-10, γ-IFN and iNOS, for which the results were comparable to untreated animals. These data are discussed in light of previous reports.

1. Introduction

Carica candamarcensis (Caricaceae) is a plant native to western South America, popularly known as mountain papaya. After injury, the leaves and outer layers of the endocarp release a large amount of latex that is rich in carbohydrates, vitamins, minerals, and proteins [1, 2]. Previously, laticifer protein fractions from C. candamarcensis were obtained by chromatography in a Sephadex column named P1G10 and P2G10 [3]. The P1G10 fraction is rich in cysteine peptidases with proteolytic activity at least five times higher than C. papaya [1, 4].

Plant peptidases are usually implicated in protein processing in response to different external stimuli and in removal of misfolded proteins [5]. These properties have proven beneficial for the treatment in vivo of worm infections caused by Heligmosomoides polygyrus with papaya latex, since peptidases promote digestion of the worms’ cuticle [6]. In particular, the fraction P1G10 of C. candamarcensis has also shown antiulcerogenic activity, similar to omeprazole or ranitidine, with effects on gastric healing that were correlated with an angiogenic stimulus [7]. P1G10 has mitogenic properties in cultured fibroblasts and epithelial cells [3] related to two peptidases already identified: CMS2MS2 and CMS2MS3 [8]. Moreover, shortening of epithelialization in a skin burn injury model was shown when P1G10 was applied at a concentration of 0.1% [9].

Previously we have shown that plant laticifer proteins can potentially be used for control of inflammatory processes derived from systemic infections [10]. Using a model of typhoid fever in rodents caused by S. enterica ser. Typhimurium, we have shown that cysteine peptidases from the laticifer fluid of Calotropis procera influence the release of proinflammatory cytokines, exhibit thrombin- and plasmin-like activities, and maintain coagulation homeostasis in septic mice [11, 12]. These protein fractions have been exploited in immunotherapy, since plant peptidases can potentially mimic endogenous human peptidases involved, for example, with coagulation, digestion, and apoptosis. In the present study, the role of P1G10 of C. candamarcensis in inflammatory response was investigated in Swiss mice experimentally infected with S. Typhimurium.

2. Methods

2.1. C. candamarcensis Latex Proteins

A voucher specimen of the plant was deposited at the herbarium of the Universidad de La Serena, Chile (number 15063). The latex was collected by several incisions on the surface of the green fruit with sharp blade. After collection, it was lyophilized and stored in the dark at −20°C until use. Then the sample was dissolved and equilibrated with sodium acetate buffer 1 M (pH 5.0) and applied in a Sephadex G10 column. The C18 column (Vydac) was equilibrated with 27% acetonitrile in 0.1% trifluoroacetic acid (TFA) before injection of 1 mg P1G10 dissolved in milli-Q water, followed by elution with a nonlinear acetonitrile-0.1% TFA gradient. Protein measurement was performed using egg-white lysozyme as standard, according to Lowry et al. [13]. The samples were screened by determining the absorbance at 280 nm and the amidase activity [3]. The first peak with amidase activity constituted the fraction P1G10.

2.2. Microorganisms

Salmonella enterica subsp. enterica ser. Typhimurium were isolated from a human clinical case sample, maintained by Ezequiel Dias Foundation (FUNED, Belo Horizonte, MG, Brazil) and was kindly provided by Dr. Jacques Robert Nicoli (Federal University of Minas Gerais, Brazil). The bacteria were kept at −18°C in brain heart infusion (BHI) culture medium containing 50% glycerol. During the experiments, the bacteria were activated by being cultured in BHI broth for 24 hours at 37°C.

2.3. In Vitro Antimicrobial Activity

The antimicrobial activity of P1G10 was assessed using the broth dilution method [14]. The proteins were dissolved in phosphate buffered saline (PBS) to give final concentrations ranging from 1 mg/mL to 0.0019 mg/mL in Mueller-Hinton broth tubes containing S. Typhimurium (105 CFU/mL). All assays were performed in duplicate. Control tubes lacked latex proteins. The minimum inhibitory concentration was estimated as the lowest concentration that inhibited visible growth after incubation for 24 h at 37°C.

2.4. Animals

All procedures were conducted in accordance with internationally accepted principles on the use of laboratory animals and were approved by the experimental ethics committee of Pernambuco Federal Rural University (Process 23082.012528/2012). Swiss mice (Mus musculus) were obtained from the collection of the Keizo Asami Immunopathology Laboratory (LIKA) of Federal University of Pernambuco. The mice weighed 30–35 grams and were kept in cages with controlled lighting (12 h light/dark cycles), 25°C with free access to water and commercial feed (Purina, Paulínia, SP, Brazil). The experiments were performed at the Microbiology and Immunology Laboratory of Federal Rural University of Pernambuco.

2.5. Experimental Peritonitis Induced by Carrageenan or Heat-Killed S. Typhimurium

The protocol was adapted from Alencar et al. [15]. The protein fraction P1G10 of C. candamarcensis was administered at concentrations of 1 or 10 mg/kg intraperitoneally (i.p.) to uninfected Swiss mice . The control groups were given PBS. After 30 minutes; the peritonitis was induced by i.p. administration of 0.2 mL of a carrageenan solution (0.5 mg/animal) or heat-killed S. Typhimurium (107 CFU/mL; 100°C/30 min). After 6 h, the animals were euthanized under anesthesia with isoflurane. For the total leukocyte count in the blood and peritoneal fluid, 20 μL was homogenized with 380 μL of the Turk reagent. An aliquot of this solution was withdrawn and placed in a Neubauer chamber, and leukocytes were counted under an optical microscope. The differential count was made from smears stained with eosin methylene blue-Giemsa [16].

2.6. Experimental Infection with S. Typhimurium

The protocol was adapted from Lima-Filho et al. [10]. Mice were divided into four groups as follows: experimental groups were i.p. administered with 0.2 mL of P1G10 in sterile PBS (137 mM NaCl, 10 mM Na2HPO4 2H2O, 2 mM KH2PO4), pH 7.2, at quantities of 1, 5, or 10 mg/kg, while the control group received 0.2 mL of PBS. After 24 hours, all animals were challenged also by the i.p. route with 0.2 mL of a suspension containing 107 CFU/mL of S. Typhimurium. The clinical symptoms and survival after infection were monitored every 24 hours for seven days. Surviving animals were subjected to euthanasia with isoflurane at the end of experiment. Two other animal groups each), administered with P1G10 (10 mg/kg) or PBS and infected with S. Typhimurium, were submitted to euthanasia 24 h or 72 h after infection, and samples of blood, peritoneal fluid, spleen, and the liver were collected for analysis.

2.7. Assessment of the Bacterial Clearance after Infection

The spleen and livers were removed aseptically and homogenized in PBS pH 7.2. The suspensions of these organs and samples of blood were submitted to serial decimal dilutions. Then, an aliquot of 0.1 mL of each dilution was plated on a MacConkey agar plate. The plates were incubated in a growth chamber for 24 h at 37°C for later quantification of the colony forming units [11].

2.8. Histopathological Analysis

Tissue samples of spleen and liver were collected after 72 h of infection of all animal groups, fixed in 10% formaldehyde and embedded in paraffin blocks. Histological sections with 5 μm thickness were stained with hematoxylin-eosin. The slides were examined by a single pathologist, who was unaware of the experimental conditions.

2.9. Assessment of Gene Expression of Inflammatory Mediators

A section of each animal’s liver was removed aseptically and homogenized in 0.5 mL of TRIzol Reagent (Invitrogen) to extract total RNA, following the protocol suggested by the manufacturer. Quantification of RNA was performed by spectrophotometry at 260 nm and its integrity was confirmed by electrophoresis on 1% agarose gel [11]. The construction of cDNA and amplification by real-time PCR were performed using a commercial kit, following the manufacturer’s instructions (Sigma-SYBR-Green Quantitative RT-PCR kit).

The following primers were used: β-actin Mouse (Internal Control) ATATCGCTGCGCTGGTCGTC 3′, 5′ AGGATGGCGTGAGGGAGAGC 3′; tumor necrosis factor-α (TNF-α) (5′ GATCTCAAAGACAACCAACTAGTG3′, 5′ CTCCAGCTGGAAGACTCCTCCCAG 3′); Ciclooxigenase-2 (COX-2) (5′ AGTTTTT CAAGACAGATCATAAGCG 3′, 5′ TGCTCCTGCTTGAGATGTCG 3′); inducible Nitric Oxide Synthase (iNOS) (5′ AAGCACATGCAGAATGAGTACCG 3′, 5′ GTGGGAC AGCTTCTGGTCGAT 3′); interleukin-10 (IL-10) (forward 5′ CGGGAAGACAATAACTG 3′, reverse 5′ CATTTCCGATAAGGCTTG 3′); and gamma-interferon (γ-IFN) (5′ GGTGAC ATGAAAATCCTGCAGAGC 3′, 5′ CGCTGGACCTGTGGGTTGTTGACC 3′).

The results were analyzed according to Dussault and Pouliot [17]. For comparison of the levels of expression of genes of interest (G.I.) between control and experimental groups, we used the following formula: The results were expressed in terms of fold variation with formula: .

2.10. Quantification of Nitric Oxide in Serum of Animals

The determination of nitric oxide in blood serum was carried out in the form of nitrite. NO was first transformed into by dioxygenation. The conversion of nitrate into nitrite was performed by the action of the enzyme nitrate reductase, using a commercial kit (R&D Systems).

2.11. Statistical Analysis

The results are expressed as mean ± standard error of the mean (SEM). For comparison of multiple parametric data, we used analysis of variance (ANOVA) followed by Bonferroni’s test or the Student-Newman-Keuls test. The significance level was . The analysis and processing of the results were performed using the GraphPad Prism program (version 5.0).

3. Results

P1G10 was not bacteriostatic or bactericidal against the strain of S. Typhimurium used for all experiments described here at any of the dosages tested. Pretreatments with P1G10 did not significantly increase the infiltration of leukocytes into the peritoneal cavity induced by carrageenan or heat-killed Salmonella (data not shown). However, the number of neutrophils in the bloodstreams of P1G10-pretreated mice was increased after injection with carrageenan , but not eosinophils, basophils, or lymphocytes (Table 1). Moreover, pretreatments with P1G10 increased the number of circulating lymphocytes when mice were injected with heat-killed Salmonella (Table 1).


Total leukocytes (103 cells/mm3)Differential leukocyte cell counts (103 cells/mm3)
EosinophilLymphocytesNeutrophilsMonocytesBasophils

P1G10 (i.p) + 0.5 mg carrageenan (i.p.)
 PBS
 1 mg/Kg
 10 mg/kg
P1G10 (i.p.) + Heat-killed Salmonella (i.p.)
 PBS
 1 mg/Kg
 10 mg/kg

Significant difference in comparison to PBS group ( ).

Survival of Swiss mice pretreated with P1G10 was dose-dependent and reached 60% of the animal group after seven days’ infection with Salmonella (Figure 1(a)). After 24 and 72 h of infection, the number of viable bacteria in blood and the spleen did not differ significantly between the animal groups . But the bacterial load in the liver of mice pretreated with P1G10 was significantly reduced 72 h after infection (Figure 1(b)). Conversely, untreated animals (PBS group) died 1–3 days after infection. There was a high infiltration of leukocytes into the peritoneal cavity of P1G10-pretreated mice 72 h after infection (Figure 1(c)). But the total leukocyte counts in the bloodstreams or the hematological profile of leukocyte populations was similar between the animal groups (data not show).

The histological evaluation of the liver of the control animals after 72 h of infection revealed inflammatory infiltration, thrombus formation, pyknotic nuclei, hepatic necrosis, and intense diffuse cytoplasmic vacuolization (Figure 2(a)). In the same period, the liver of animals pretreated with P1G10 showed mild vacuolization of hepatocytes, mild signs of necrosis, presence of microabscesses and accumulations of mononuclear cells (Figure 2(b)). The analysis of the spleen of control animals 72 h after infection revealed that the presence of splenic parenchyma in areas of inflammation and necrosis in lymphoid depletion with multinucleated cells (Figure 2(c)), while the spleen of animals pretreated with P1G10 only had slight inflammation and absence of multinucleated giant cells (Figure 2(d)).

The examination of mRNA transcripts of inflammatory mediators in liver cells 24 h after infection confirmed fold variation increases of 5.8 and 4.8 on average for IL-1 and COX-2, respectively, in mice pretreated with P1G10 (Figures 3(a) and 3(b)). Conversely, the gene expression levels of TNF-α, IL-10, γ-IFN, and iNOS were comparable to untreated animals (Figure 3(a)). Indeed, the NO serum levels in experimental mice were not particularly altered in comparison to the control ones 72 h after infection (Figure 3(c)).

4. Discussion

S. Typhimurium provokes a syndrome similar to the human typhoid fever caused by S. Typhi in the murine model, which has been used to study severe inflammatory processes derived from bacterial infections [18, 19]. Systemic infections caused by Salmonella typically induce the failure of leukocyte migration to the infection site, among other inflammatory disorders, leading to septic shock and death [20, 21]. In the present study, we have shown that P1G10 has immunomodulatory properties, which varied between infected and uninfected models.

Preliminary assays that used carrageenan or heat-killed Salmonella as phlogistic agents have shown that P1G10 stimulated the proliferation of circulating neutrophils and lymphocytes, which are important for resistance against salmonelosis [22]. Although the hematological profile was not particularly affected in a real infection, pretreatments with P1G10 increased the survival of mice after a lethal inoculum of S. Typhimurium in a dose-dependent manner. This protective effect was confirmed through histological examination in the main target organs of infection, the liver and spleen. Additionally, the infiltration of leukocytes into the peritoneal cavity was only significant in mice pretreated with P1G10 after infection (but not after carrageenan or heat-killed Salmonella injection). Since Salmonella actually have the ability to grow in the peritoneal cavity after i.p. inoculums, we hypothesize that P1G10 immunomodulation was boosted by the continuous intracellular bacterial growth into target organs during the infection.

As an attempt to explain the above results, we investigated the influence of P1G10 on inflammatory mediators. The activation of proinflammatory cytokines such as TNF-α and IL-1β is important for host resistance against Salmonella, since they induce maturation of dendritic cells with implications on initiation of the adaptive immune response [23]. Moreover, nitric oxide (NO) is often released after the inducible nitric oxide synthase (iNOS) is triggered by cytokines such as TNF-α and IFN-γ [19]. However, our data show that mRNA expression levels of both TNF-α and IFN-γ were comparable to the control mice, which died one to three days after infection. In spite of the microbicidal role of NO in the intracellular environment, which could explain the lower number of colony forming units in the liver of experimental mice 72 h after infection, it was apparently not decisive to increase survival of experimental mice.

High serum levels of TNF-α have been shown to increase the severity of septic infections, while mice deficient in the production of IL-1β are resistant to septic shock [2426]. On the other hand, mRNA transcripts of IL-1β and COX-2 were upregulated in mice pretreated with P1G10 after infection. Interleukin-1β has as main source macrophages stimulated by TNF-α or bacterial LPS and is responsible for promoting the recruitment of leukocytes to the infection site [20]. Furthermore, COX-2 enzyme is inducible by inflammation, converting arachidonic acid to prostaglandin, with its regulation being dependent on IL-1 among other stimuli [27]. Prostaglandin E2 (PGE2) exerts local inflammation and phagocyte-mediated immunity at the infection site but has anti-inflammatory properties in extended immune responses [28]. Although Salmonella infection naturally augments COX-2 mRNA expression and PGE2 synthesis [29], P1G10 pretreatments apparently contribute to recruitment and activation of leukocytes in early infection.

Previous studies have shown different effects of plant peptidases on inflammatory response. For example, bromelain, a mix of peptidases derived from pineapple stem with anti-inflammatory properties, affects T-cell mRNA expression of IL-2, IL-4, and IFN-γ in colon epithelial cell lines [30, 31]. Bromelain also blocks S. Typhimurium induced ERK-1, ERK-2, and c-Jun NH2-terminal kinase (JNK) activation in Caco-2 cells [32]. Additionally we have shown that laticifer peptidases of C. procera promote downregulation of IL-1β, among other inflammatory mediators, during infection by S. Typhimurium [10, 11]. In general, plant peptidases appears to exert their biological actions indirectly on immune cells due to the proteolytic cleavage of membrane surface molecules triggering (or abrogating) the inflammatory cascade [33, 34]. For instance, peptidases of C. candamarcensis is shown to stimulate proliferation of specific cell lines such as L929, MDA-MB231, and BHK-21 [35], and this effect was further associated with an increase in activity of Erk2, a component of the MAP kinase pathway [8]. Since the MAPK/ERK pathway is involved in IL-1β-induced COX-2 expression and PGE2 production [36], it is reasonable to assume that pretreatments with P1G10 potentially influenced the MAP kinase pathway in vivo after infection by Salmonella.

Although the specific mechanism enhanced by P1G10 in the immune system is still to be elucidated, we have shown that early activation of inducible proinflammatory mediators possibly contributed to local bacterial killing, increasing the survival of mice after infection. Moreover, activation was not downregulated by IL-10, since no mRNA transcripts were detected for the cytokine in early infection. Since medicinal plants have been traditionally used for prevention of infectious diseases caused by different etiological agents, the clinical relevance of P1G10 is clear. Finally, we conclude that P1G10 is a source of immunomodulatory proteases that could be used for activation of the immune response against intracellular pathogens.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

This study was funded by the Brazilian National Council for Scientific and Technological Research (CNPq) (Grant no. 562664/2010-6). The first author received an M.S. scholarship from CAPES agency, Brazil. The authors also thank Dr. Maria Helena Ribeiro for supplying the animals used in the present study.

References

  1. G. Baeza, D. Correa, and C. E. Salas, “Proteolytic enzymes in Carica candamarcensis,” Journal of the Science of Food and Agriculture, vol. 51, pp. 1–9, 1990. View at: Google Scholar
  2. V. Walraevens, M.-C. Vandermeers-Piret, A. Vandermeers, P. Gourlet, and P. Robberecht, “Isolation and primary structure of the CCI papain-like cysteine proteinases from the latex of Carica candamarcensis hook,” Biological Chemistry, vol. 380, no. 4, pp. 485–488, 1999. View at: Publisher Site | Google Scholar
  3. C. A. Silva, M. T. R. Comes, R. S. Ferreira et al., “A mitogenic protein fraction in latex from Carica candamarcensis,” Planta Medica, vol. 69, no. 10, pp. 926–932, 2003. View at: Publisher Site | Google Scholar
  4. R. D. Teixeira, H. A. L. Ribeiro, M.-T. R. Gomes, M. T. P. Lopes, and C. E. Salas, “The proteolytic activities in latex from Carica candamarcensis,” Plant Physiology and Biochemistry, vol. 46, no. 11, pp. 956–961, 2008. View at: Publisher Site | Google Scholar
  5. M. Grudkowska and B. Zagdańska, “Multifunctional role of plant cysteine proteinases,” Acta Biochimica Polonica, vol. 51, no. 3, pp. 609–624, 2004. View at: Google Scholar
  6. G. Stepek, A. E. Lowe, D. J. Buttle, I. R. Duce, and J. M. Behnke, “The anthelmintic efficacy of plant-derived cysteine proteinases against the rodent gastrointestinal nematode, Heligmosomoides polygyrus, in vivo,” Parasitology, vol. 134, no. 10, pp. 1409–1419, 2007. View at: Publisher Site | Google Scholar
  7. V. J. Mello, M. T. R. Gomes, F. O. Lemos et al., “The gastric ulcer protective and healing role of cysteine proteinases from Carica candamarcensis,” Phytomedicine, vol. 15, no. 4, pp. 237–244, 2008. View at: Publisher Site | Google Scholar
  8. M. T. R. Gomes, V. J. Mello, K. C. Rodrigues et al., “Isolation of two plant proteinases in latex from Carica candamarcensis acting as mitogens for mammalian cells,” Planta Medica, vol. 71, no. 3, pp. 244–248, 2005. View at: Publisher Site | Google Scholar
  9. F. S. L. Gomes, C. de V. Spínola, H. A. Ribeiro, M. T. P. Lopes, G. D. Cassali, and C. E. Salas, “Wound-healing activity of a proteolytic fraction from Carica candamarcensis on experimentally induced burn,” Burns, vol. 36, no. 2, pp. 277–283, 2010. View at: Publisher Site | Google Scholar
  10. J. V. Lima-Filho, J. M. Patriota, A. F. B. Silva et al., “Proteins from latex of Calotropis procera prevent septic shock due to lethal infection by Salmonella enterica serovar Typhimurium,” Journal of Ethnopharmacology, vol. 129, no. 3, pp. 327–334, 2010. View at: Publisher Site | Google Scholar
  11. R. S. B. Oliveira, I. S. T. Figueiredo, L. B. N. Freitas et al., “Inflammation induced by phytomodulatory proteins from the latex of Calotropis procera (Asclepiadaceae) protects against Salmonella infection in a murine model of typhoid fever,” Inflammation Research, vol. 61, pp. 689–698, 2012. View at: Publisher Site | Google Scholar
  12. M. V. Ramos, C. A. Viana, A. F. B. Silva et al., “Proteins derived from latex of C. procera maintain coagulation homeostasis in septic mice and exhibit thrombin- and plasmin-like activities,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 385, pp. 455–463, 2012. View at: Publisher Site | Google Scholar
  13. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at: Google Scholar
  14. E. W. Koneman, S. D. Allen, W. M. Janda, P. C. Schreckenberger, and W. C. Winn, Diagnóstico microbiológico: texto e atlas colorido, MEDSI, Rio de Janeiro, Brazil, 2008.
  15. N. M. N. Alencar, I. S. T. Figueiredo, M. R. Vale et al., “Anti-inflammatory effect of the latex from Calotropis procera in three different experimental models: Peritonitis, paw edema and hemorrhagic cystitis,” Planta Medica, vol. 70, no. 12, pp. 1144–1149, 2004. View at: Publisher Site | Google Scholar
  16. G. E. P. De Souza and S. H. Ferreira, “Blockade by antimacrophage serum of the migration of PMN neutrophils into the inflamed peritoneal cavity,” Agents and Actions, vol. 17, no. 1, pp. 97–103, 1985. View at: Google Scholar
  17. A.-A. Dussault and M. Pouliot, “Rapid and simple comparison of messenger RNA levels using real-time PCR,” Biological Procedures Online, vol. 8, no. 1, pp. 1–10, 2006. View at: Publisher Site | Google Scholar
  18. S. Zhang, R. A. Kingsley, R. L. Santos et al., “Molecular pathogenesis of Salmonella enterica serotype typhimurium-induced diarrhea,” Infection and Immunity, vol. 71, no. 1, pp. 1–12, 2003. View at: Publisher Site | Google Scholar
  19. P. Mastroeni and A. J. Grant, “Spread of Salmonella enterica in the body during systemic infection: unravelling host and pathogen determinants,” Expert Reviews in Molecular Medicine, vol. 13, article e12, 2011. View at: Publisher Site | Google Scholar
  20. C. F. Benjamim, “Present understanding of mediators and experimental models of sepsis,” Medicina, vol. 34, pp. 18–26, 2001. View at: Google Scholar
  21. J. C. Alves-Filho, C. Benjamim, B. M. Tavares-Murta, and F. Q. Cunha, “Failure of neutrophil migration toward infectious focus in severe sepsis: a critical event for the outcome of this syndrome,” Memorias do Instituto Oswaldo Cruz, vol. 100, no. 1, pp. 223–226, 2005. View at: Google Scholar
  22. A. Berndt, J. Pieper, and U. Methner, “Circulating γδ T cells in response to Salmonella enterica serovar enteritidis exposure in chickens,” Infection and Immunity, vol. 74, no. 7, pp. 3967–3978, 2006. View at: Publisher Site | Google Scholar
  23. T. Van Der Poll and H. P. Sauerwein, “Tumour necrosis factor-α: its role in the metabolic response to sepsis,” Clinical Science, vol. 84, no. 3, pp. 247–256, 1993. View at: Google Scholar
  24. L. C. Casey, R. A. Balk, and R. C. Bone, “Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome,” Annals of Internal Medicine, vol. 119, no. 8, pp. 771–778, 1993. View at: Google Scholar
  25. B. Gardlund, J. Sjolin, A. Nilsson, M. Roll, C.-J. Wickerts, and B. Wretlind, “Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity,” Journal of Infectious Diseases, vol. 172, no. 1, pp. 296–301, 1995. View at: Google Scholar
  26. P. Li, H. Allen, S. Banerjee et al., “Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock,” Cell, vol. 80, no. 3, pp. 401–411, 1995. View at: Google Scholar
  27. W. L. Smith and L. J. Marnett, “Prostaglandin endoperoxide synthase: Structure and catalysis,” Biochimica et Biophysica Acta, vol. 1083, no. 1, pp. 1–17, 1991. View at: Publisher Site | Google Scholar
  28. P. Kalinski, “Regulation of immune responses by prostaglandin E2,” Journal of Immunology, vol. 188, no. 1, pp. 21–28, 2012. View at: Publisher Site | Google Scholar
  29. C. C. Bowman and K. L. Bost, “Cyclooxygenase-2-mediated prostaglandin E2 production in mesenteric lymph nodes and in cultured macrophages and dendritic cells after infection with Salmonella,” Journal of Immunology, vol. 172, no. 4, pp. 2469–2475, 2004. View at: Google Scholar
  30. T. L. Mynott, A. Ladhams, P. Scarmato, and C. R. Engwerda, “Bromelain, from pineapple stems, proteolytically blocks activation of extracellular regulated kinase-2 in T cells,” Journal of Immunology, vol. 163, no. 5, pp. 2568–2575, 1999. View at: Google Scholar
  31. L. P. Hale, D. J. Fitzhugh, and H. F. Staats, “Oral immunogenicity of the plant proteinase bromelain,” International Immunopharmacology, vol. 6, no. 13-14, pp. 2038–2046, 2006. View at: Publisher Site | Google Scholar
  32. T. L. Mynott, B. Crossett, and S. R. Prathalingam, “Proteolytic inhibition of Salmonella enterica serovar Typhimurium-induced activation of the mitogen-activated protein kinases ERK and JNK in cultured human intestinal cells,” Infection and Immunity, vol. 70, no. 1, pp. 86–95, 2002. View at: Publisher Site | Google Scholar
  33. L. P. Hale and B. F. Haynes, “Bromelain treatment of human T cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, CD8, and Leu 8/LAM1 surface molecules and markedly enhances CD2-mediated T cell activation,” Journal of Immunology, vol. 149, no. 12, pp. 3809–3816, 1992. View at: Google Scholar
  34. L. P. Hale, P. K. Greer, and G. D. Sempowski, “Bromelain treatment alters leukocyte expression of cell surface molecules involved in cellular adhesion and activation,” Clinical Immunology, vol. 104, no. 2, pp. 183–190, 2002. View at: Publisher Site | Google Scholar
  35. C. A. Silva, M. T. R. Comes, R. S. Ferreira et al., “A mitogenic protein fraction in latex from Carica candamarcensis,” Planta Medica, vol. 69, no. 10, pp. 926–932, 2003. View at: Publisher Site | Google Scholar
  36. X. Wang, F. Li, C. Fan, C. Wang, and H. Ruan, “Analysis of isoform specific ERK signaling on the effects of interleukin-1β on COX-2 expression and PGE2 production in human chondrocytes,” Biochemical and Biophysical Research Communications, vol. 402, no. 1, pp. 23–29, 2010. View at: Publisher Site | Google Scholar

Copyright © 2014 Maria Taciana Ralph et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

969 Views | 570 Downloads | 1 Citation
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.